Completing data — refresh the page later to see the latest
199596-05-9Clc1ccc(N/N=C(\c2ccccc2)c2ccccn2)nc1YHHFKWKMXWRVTJ-OQKWZONESA-N199596-05-9、909077-07-2Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
DescriptionJIB-04 (199596-05-9) is a novel specific inhibitor of the Jumonji family of histone demethylasesin vitro, in cancer cells and in tumorsin vivo.IC50= 230, 340, 435, 445, 855 and 1100 nM for JARID1A, JMJD2E, JMJD2B, JMJD2A, JMJD3 and JMJD2C respectively.Reduces tumor burden and prolongs life in a mouse model.1Suppresses translation initiation and enhances mTOR inhibitor sensitivity.2Inhibits the growth of temozolomide-resistant glioblastoma cells and crosses the blood brain barrier.3
UsesJIB-04 is a specific inhibitor of Jumonji demethylases.
UsesJIB-04 has been used in sulforhodamine B cell growth assay. It has also been used as a control to determine the inhibitory action of ML324 on KDM4A (histone lysine demethylase 4A).
DTXSID101356831CHEMBL1982368